rs5334
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001957.4(EDNRA):c.1005G>A(p.Glu335=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,608,528 control chromosomes in the GnomAD database, including 64,432 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.34 ( 10502 hom., cov: 31)
Exomes 𝑓: 0.26 ( 53930 hom. )
Consequence
EDNRA
NM_001957.4 synonymous
NM_001957.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.41
Genes affected
EDNRA (HGNC:3179): (endothelin receptor type A) This gene encodes the receptor for endothelin-1, a peptide that plays a role in potent and long-lasting vasoconstriction. This receptor associates with guanine-nucleotide-binding (G) proteins, and this coupling activates a phosphatidylinositol-calcium second messenger system. Polymorphisms in this gene have been linked to migraine headache resistance. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 4-147539921-G-A is Benign according to our data. Variant chr4-147539921-G-A is described in ClinVar as [Benign]. Clinvar id is 1255371.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.41 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.565 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EDNRA | NM_001957.4 | c.1005G>A | p.Glu335= | synonymous_variant | 6/8 | ENST00000651419.1 | NP_001948.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EDNRA | ENST00000651419.1 | c.1005G>A | p.Glu335= | synonymous_variant | 6/8 | NM_001957.4 | ENSP00000498969 | P1 |
Frequencies
GnomAD3 genomes AF: 0.341 AC: 51704AN: 151758Hom.: 10492 Cov.: 31
GnomAD3 genomes
AF:
AC:
51704
AN:
151758
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.278 AC: 68835AN: 247346Hom.: 10837 AF XY: 0.276 AC XY: 36828AN XY: 133648
GnomAD3 exomes
AF:
AC:
68835
AN:
247346
Hom.:
AF XY:
AC XY:
36828
AN XY:
133648
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.263 AC: 383536AN: 1456652Hom.: 53930 Cov.: 33 AF XY: 0.265 AC XY: 191797AN XY: 724456
GnomAD4 exome
AF:
AC:
383536
AN:
1456652
Hom.:
Cov.:
33
AF XY:
AC XY:
191797
AN XY:
724456
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.341 AC: 51732AN: 151876Hom.: 10502 Cov.: 31 AF XY: 0.335 AC XY: 24898AN XY: 74224
GnomAD4 genome
AF:
AC:
51732
AN:
151876
Hom.:
Cov.:
31
AF XY:
AC XY:
24898
AN XY:
74224
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1044
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Mandibulofacial dysostosis with alopecia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at